We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Models Evaluated for Spotting Ischemic Stroke Lesions on Routine MRI

By HospiMedica International staff writers
Posted on 16 Sep 2026

Rapid detection of ischemic stroke on brain MRI is essential because treatment benefit declines with time. More...

Many centers first acquire contrast-free MRI FLAIR sequences because they are quick and broadly available in routine care. These images are challenging for automated analysis due to faint, irregular lesions and scanner variability. A new study published ahead of print in the Journal of Intelligent Systems in Current Computer Engineering evaluates three deep learning methods to improve lesion identification on FLAIR.

The evaluation compared three deep-learning approaches: a conventional 3D U-Net, the self-configuring nnU-Net framework, and an adapted YOLOv8 model configured for 2D segmentation. The researchers aimed to determine which method could most accurately delineate stroke lesions on contrast-free MRI under conditions reflecting routine clinical imaging. To enable a direct comparison, all three models were implemented within the same training and preprocessing pipeline.

The models were trained and tested using the ISLES 2022 benchmark, which includes 250 stroke MRI cases. Identical preprocessing and evaluation procedures were applied across all methods to minimize methodological differences. Segmentation performance was assessed using the Dice similarity coefficient and Intersection over Union, established measures of overlap between model-generated segmentations and expert annotations.

The self-configuring nnU-Net achieved the highest average agreement with expert-marked lesions, with a Dice score of approximately 0.483. The adapted YOLOv8 model performed similarly, with a Dice score of about 0.476, while processing images substantially faster than the other approaches, suggesting potential advantages when throughput is important. The manually tuned 3D U-Net performed less well overall, achieving a Dice score of approximately 0.294 and highlighting its greater sensitivity to parameter selection and variability in multicenter MRI data.

Error analysis showed that all three approaches struggled with small peripheral lesions, diffuse low‑contrast injury, and cases with imperfect spatial alignment. Preprocessing steps such as harmonizing voxel spacing, normalizing intensity, and training on smaller image patches improved model behavior. The authors recommend prioritizing self‑configuring frameworks like nnU‑Net for robustness when compute permits and considering lightweight architectures like YOLOv8 when speed is critical. They emphasize that rigorous multi‑site validation across scanners and institutions is essential before deployment in clinical workflows.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Pediatric Mask
Respire SOFT
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.